Director, Patient-Centered Outcomes & PRO Strategy

Jazz Pharmaceuticals; California; On-site; USD 212,000 - 318,000; Full time

Job summary

Jazz Pharmaceuticals seeks a Director of Patient-Centered Outcomes to architect and lead global COA, PED, and PRO strategies for oncology launches and lifecycle programs. You will balance scientific rigor with market access timelines, delivering patient-focused evidence to health authorities, payers, clinicians, and patients worldwide.

The role requires 8–10+ years in PCO/COA/PRO with regulatory interaction expertise, and oversight of eCOA/ePRO implementation across 40+ countries.

Qualifications

• 8–10+ years in PCO/COA/PRO/HEOR within pharma or consulting.
• Experience driving COA/PRO strategies for oncology launches and lifecycle programs.
• Regulatory briefing document authoring and engagement with health authorities.
• Hands-on experience with global eCOA/ePRO trial operations and vendor management.

Responsibilities

• Lead end-to-end COA/PRO strategies for launch and lifecycle brands.
• Collaborate with GVHEOR to integrate PRO endpoints into economic models and dossiers.
• Oversee regulatory strategy, label negotiations, and scientific advice procedures.
• Mentor junior scientists and supervise external vendors and partners.

Skills

PCO Experience

COA/PRO Expertise

Regulatory Interaction

Education

MS/MPH or PhD/PharmD/MD in relevant field

Job description

Jazz Pharmaceuticals seeks a Director of Patient-Centered Outcomes to architect and lead global COA, PED, and PRO strategies for oncology launches and lifecycle programs. You will balance scientific rigor with market access timelines, delivering patient-focused evidence to health authorities, payers, clinicians, and patients worldwide.

The role requires 8–10+ years in PCO/COA/PRO with regulatory interaction expertise, and oversight of eCOA/ePRO implementation across 40+ countries.